New Grants Support Organizations Prioritizing Diversity and Diagnosis in their Disease Areas CHARLOTTESVILLE, VA (November 3, 2021) — Today, the Chan Zuckerberg Initiative (CZI) announced $13 million in funding for…
Alliance to Cure Cavernous Malformation is excited to announce a new addition to its growing network of Centers of Excellence. The organization has recognized Penn Medicine/The Hospital of the University…
The North American clinicians on the Alliance to Cure Cavernous Malformation Scientific Advisory Board have issued an updated COVID-19 statement that includes information from the COVID-19 registry on COVID risk…
The summer newsletter contains research news you may have missed, information about upcoming events, program announcements, and more. Stay in the know! Summer 2021 Newsletter
Rho Kinase Inhibitor BA-1049 Moving Forward for CCM. The medicine being developed by BioAxone to treat CCM has been licensed to Neurelis to move forward to trials. Neurelis intends to…
